Provided by Tiger Trade Technology Pte. Ltd.

Global X Genomics & Biotechnology ETF

63.57
+1.352.17%
Post-market: 63.40-0.1689-0.27%19:30 EDT
Volume:11.27K
Turnover:710.22K
Market Cap:95.65M
PE:- -
High:63.76
Open:62.31
Low:62.22
Close:62.22
52wk High:68.00
52wk Low:36.13
Shares:1.50M
Float Shares:1.50M
Volume Ratio:0.23
T/O Rate:0.75%
Dividend:0.65
Dividend Rate:1.02%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

U.S. Stocks on the MOVE-Sigma Lithium, Shake Shack, Novartis

Reuters
·
Sep 08

Analysts Offer Insights on Healthcare Companies: Amgen (AMGN), Guardant Health (GH) and Neurocrine (NBIX)

TIPRANKS
·
Sep 08

Structure Therapeutics reports ACCG-2671, aleniglipron trial results

TIPRANKS
·
Sep 08

Guardant Health Price Target Announced at $203.00/Share by Rothschild & Co

Dow Jones
·
Sep 08

【US Pre-Market】Middle East Energy Risks Escalate, Brent Crude Nears $100, Oil and Gas Stocks Rise; Novartis Plunges 13%

TradingKey
·
Sep 08

Intel, Amgen, Novartis, Bloom Energy, and More Stocks That Explain Today's Market

Dow Jones
·
Sep 08

Guardant Health's Breast Cancer Diagnostic Approved by US FDA

MT Newswires Live
·
Sep 08

Rothschild & Co Redburn Initiates Guardant Health at Buy

MT Newswires Live
·
Sep 08

Everpure, Illumina Gain on S&P 500 Inclusion

Reuters
·
Sep 08

Guardant Health initiated with a Buy at Rothschild & Co Redburn

TIPRANKS
·
Sep 08

Natera initiated with a Buy at Rothschild & Co Redburn

TIPRANKS
·
Sep 08

Milton Essex boosts Sanford Biotech capital to drive advanced mastitis cell therapy

TIPRANKS
·
Sep 08

The Second Act of Biotech

TIPRANKS
·
Sep 07

Insiders Shake Up Innovative, Alcoa, Illumina, Southern, Marathon

TIPRANKS
·
Sep 05

S&P 500 Quarterly Shake-Up: AI Demand Propels Bloom Energy Into the Index, Alongside Illumina and Everpure

Stock News
·
Sep 05

Bloom Energy, Illumina, and Everpure Set to Join S&P 500; Others to Join S&P 100, S&P MidCap 400, and S&P Smallcap 600

THOMSON REUTERS
·
Sep 05

Illumina Director Keith Meister Disposes of USD 30.51 Million in Common Shares

Reuters
·
Sep 05

Guardant announces FDA approval of Guardant360 CDx as companion diagnostic

TIPRANKS
·
Sep 05

Guardant Health Announces Landmark FDA Approval of Guardant360® Cdx as Companion Diagnostic for AstraZeneca’s Etcamah™ (Camizestrant) in Advanced Breast Cancer

THOMSON REUTERS
·
Sep 05

S&P Dow Jones Indices: Bloom Energy, Illumina, and Everpure Set to Join S&P 500

THOMSON REUTERS
·
Sep 05